Cell & Gene Meeting on the Med
Vivet Therapeutics is heading to Rome for the 2024 Cell & Gene Meeting on the Med from 9 – 11 April. Come and listen to our CEO, @Jean-Philippe Combal on 9 April at 10am CEST, where he will deliver a presentation on hashtag#Vivet‘s diversified pipeline of hashtag#rAAV based hashtag#genetherapies for rare inherited liver metabolic disorders […]
7th Annual Gene Therapy for Rare Disorders Summit
Vivet Therapeutics Chief Executive Officer, Jean-Philippe Combal will be attending the 7th Annual Gene Therapy for Rare Disorders Summit, taking place from 26-29 March in Boston, MA!
Rare Disease Day – February 29
To mark #RareDiseaseDay on 29 February, our CEO Jean-Philippe Combal, spoke to pharmaphorum
Vivet Therapeutics receives EUR 4.9 million to advance development of a gene therapy
PRESS RELEASE Vivet Therapeutics receives EUR 4.9 million to advance development of a gene therapy for the treatment of cerebrotendinous xanthomatosis
J.P.Morgan 2024 – Annual Healthcare Conference in San Francisco
Jean-Philippe Combal – CEO and Gloria Gonzalez – CSO, are going to San Francisco for #JPM24! Let’s make the most of this opportunity. Please send a message if you would like to schedule a meetup: info@vivet-therapeutics.com. #Wilsonsdisease #genetherapy #innovation #letsconnect
Vivet spronsoring and attending the Spanish Wilson disease patients association annual conference in Valencia, Spain
The Vivet Therapeutics team had the honor of sponsoring and attending the Spanish Wilson’s Disease Association meeting in Valencia, Spain (learn more: https://lnkd.in/eUMB-AUw ) over the last weekend.
